Treating Cluster Headaches with Non-Invasive Vagal Nerve Stimulator

Video

At AAN 2017, Peter Goadsby, M.B., B.S., Director of the NIHR- Wellcome Trust King’s Clinical Research, London, Professor of Neurology, University of California at San Francisco, discussed the recent FDA approval of the gammaCore non-invasive vagal nerve stimulator. Goadsby believed this would have a significant impact on patients with cluster headache. It’s an acute treatment; so it’s a way of treating the attacks that come.


Related Videos
Anita Clayton, MD: Zuranolone for Postpartum Depression
Mikkael Sekeres, MD:
Lynn Malec, MD: FVIII Therapy Improves Levels in Pediatric Patients with Hemophilia A
Lynn Malec, MD:
Guy Young, MD: More Advancement for Subcutaneous Hemophilia Treatments
Guy Young, MD
Margaret Ragni, MD: Liver Abnormalities in Hemophilia A Gene Therapy Require Close Monitoring
Related Content
© 2023 MJH Life Sciences

All rights reserved.